Budesonide Orodispersible Tablets are Highly Effective for Treatment of Active Eosinophilic Esophagitis: Results from a Randomized, Double-Blind, Placebo-Controlled, Pivotal Multicenter Trial (EOS-1)
Alfredo J. Lucendo(Hospital General de Tomelloso), Alex Straumann(University of Zurich), Alain Schoepfer(University Hospital of Lausanne), Ralph Müeller(Dr Falk Pharma (Germany)), Michael Vieth(Bayreuth Medical Center), Stefan Schubert, Ulrike von Arnim, Jan Tack(KU Leuven), Albert J. Bredenoord(Amsterdam Neuroscience), Dirk Hartmann, Christoph Schlag, Stefan Brückner, Stephan Miehlke(University Medical Center Hamburg-Eppendorf), Javier Molina‐Infante(Complejo Hospitalario de Cáceres), Roland Greinwald(Dr Falk Pharma (Germany)), Constanza Ciriza de los Ríos(Hospital Clínico San Carlos), Jamal Hayat, Stephen E. Attwood(Durham University), Ahmed Madisch(Technische Universität Dresden)
Cited by 13
Related Papers
Functional Gastroduodenal Disorders
|Gastroenterology|2006|2.4k
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
|Gastroenterology|2020|2.1k
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k